Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Total Non-Current Liabilities ₹187 Cr₹199 Cr₹169 Cr₹107 Cr₹103 Cr

What is the latest Total Non-Current Liabilities ratio of MANKIND PHARMA ?

The latest Total Non-Current Liabilities ratio of MANKIND PHARMA is ₹187 Cr based on Mar2024 Consolidated results.
Year Total Non-Current Liabilities
Mar2024₹187 Cr
Mar2023₹199 Cr
Mar2022₹169 Cr
Mar2021₹107 Cr
Mar2020₹103 Cr

How is Total Non-Current Liabilities of MANKIND PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2024 ₹187 Cr
-5.97
Mar2023 ₹199 Cr
18.12
Mar2022 ₹169 Cr
57.15
Mar2021 ₹107 Cr
4.17
Mar2020 ₹103 Cr -

Compare Total Non-Current Liabilities of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹98,123.6 Cr 1.3% -4.8% 9.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,068.0 Cr 1.4% 0.1% 13.9% Stock Analytics
DIVIS LABORATORIES ₹177,105.0 Cr 0.8% 12.3% 47.2% Stock Analytics
CIPLA ₹122,016.0 Cr 2.6% -0.1% 0.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,651.0 Cr 7.8% 12.9% 13.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,942.0 Cr 2.7% -0.6% 14.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.3%

-4.8%

9.3%

SENSEX

2.1%

3.7%

14.3%


You may also like the below Video Courses